Dr. Marc Facciotti’s spent over 10 years mentoring UC Davis iGEM teams as an iGEM PI. Learn from him the ingredients of a successful iGEM team.

Read Dr. Mayi Arcellana-Panlilio’s journey as a PI of iGEM Calgary team, mentoring students to explore synthetic biology, lead interdisciplinary projects, build startups and achieve success across diverse career paths.

Learn about Dr. Thomas Gorochowski’s journey with iGEM, from starting the first Bristol team to mentoring future iGEMers, showcasing iGEM’s impact on his career

Meet Eric Herrera, the co-founder and CEO of Maverick Biometals, a finalist in the 2022 iGEM Startup Showcase in 2022 and Y Combinator S22 Cohort. Eric shared his remarkable entrepreneurship journey, starting with a single bench in a Baltimore basement to a 10,000 sq. ft. biotechnology laboratory. With a team of scientists from over 10 countries, Maverick Biometals is pioneering the production of lithium batteries and silicon semiconductors entirely through biological methods

2024 has been an incredible year for iGEM Startups, marked by notable funding trends among iGEM Alumni startups, particularly at the intersection of artificial intelligence (AI) and synthetic biology (SynBio) within our ecosystem. This year alone, seven alumni startups have secured over $95 million in funding—from government grants to multimillion-dollar investments—highlighting the scalability and market potential of these groundbreaking technologies.

Ashwin Jainarayanan is a biofounder with a deep-rooted passion for advancing medical science through synthetic biology and immuno-oncology. Ashwin's journey of founding Granza Bio began during his PhD at the University of Oxford, when a serendipitous email mix-up connected him with Ashwin Nandakumar, who was working on another project at a nearby department. 

Get insights in to successful iGEM Competition teams and their projects and learn from them the tips and tricks that can help you have a successful iGEM competition season.

Nicolas Krink, CEO BioHalo, joins us for the BioFounders Interview. This series delves into the firsthand stories of iGEMers venturing into entrepreneurship. Documenting challenges, opportunities, experiences, and lessons for other startup founders.

Rare Disease Day is observed on the last day of February to raise awareness about rare diseases and improve access to treatment and medical representation. This article covers the barriers in therapy progress, communication and how are iGEM teams tackling rare diseases with synthetic biology

Neha attended the BWC working group as part of the Nuclear Threat Initiative's (NTI) 2023 youth delegation. In this article, she summarized insights from formal and informal discussions, as well as side events held during the meeting

Read about the common challenges that bio-startups and biofounders face in their entrepreneurship journey and what are the possible solutions to overcome those challenges?

Take a looking how iGEM Teams from around the world are restoring Earth's health applying the tools and techniques of synthetic biology for Bioremediation.

Camila Gaspar Quinonez shares her passion for protecting the earth, leveraging the power of synthetic biology, working with microbes, and taking care what’s left of our planet in this alumni feature for the iGEM Blog.

This blog reflects on how iGEM's emphasis on articulating complex ideas to the public and bridging the gap between diverse teams became invaluable skills in Michael Wahba’s Master of Fine Arts journey. Explore the seamless integration of scientific communication and creative collaboration.

Read about Janella Schwab’s synthetic biology from being a part of a high-school iGEM team in Peru and joining the UBC iGEM team in Canada to starting her PhD in Bioengineering at Standford, USA in this blog by our iGEM Ambassadors from North America

Synthetic biology, a realm where science fiction and reality intertwine, has paved the way for countless innovations that hold the potential to revolutionize the world as we know it. In this blog, we delve into the synthetic biology journey of Sandra Waterwood Acquah, a name synonymous with innovation, inspiration, and impact.

We dive into the captivating journey of Prince Edem Samoh, a remarkable individual who is at the forefront of using synthetic biology to solve local problems in Africa. With a passion for innovation, collaboration, and education, Prince's story illuminates the boundless possibilities that lie ahead for synthetic biology on the African continent.

In the 2nd session of the BridgeBio project’s ‘Leading Ladies of SynBio’ series, we hosted Dr. Claire Aldridge. Dr. Aldridge is an experienced innovator, scientist and chief strategy officer at Form Bio, a leading biotechnology company.

Neurodegenerative diseases comprise a broad spectrum of disorders resulting from the gradual deterioration of cells and connections within the nervous system, crucial for functions such as movement, coordination, strength, sensation, and cognition. Explore how iGEM team’s have tackled the disease through their innovative diagnostic and therapeutic solutions.

Dive deeper into an exciting journey of endless curiosity of what is called “Frugal Science”, highlight notable innovations like the Foldscope and share the inspiring story of an iGEM Team from the Lambert high school who grabbed a gold medal at the 2018 Giant Jamboree with their frugal innovation project.

Discover the lessons learned from the successful journey of Neocycle, where science and entrepreneurship converge. This article highlights how Arshia Mostoufi and his team navigated the challenges of combining synthetic biology research with entrepreneurial endeavors.

Porfirio participated in iGEM for the first time in 2011 as a part of the first iGEM team from Universidad Autonoma de Nuevo Leon. He is currently working as a Design Engineer at Ginkgo Bioworks.

In the inaugural session of the BridgeBio project’s ‘Leading Ladies of SynBio’ series, we hosted Dr. Aoife Brennan. Dr. Brennan is an experienced physician, Scientist and CEO of Synlogic Therapeutics, a leading biotechnology company.

Learn how an iGEMer from Japan started her Synthetic Biology journey in Sweden. How participating in iGEM helped her in her career and overcoming challenges.

An interview with Taku Tsuzuki, CTO of Epistra Inc. and member of iGEM Osaka 2012 & 2013 (Leader) from Japan. He is an entrepreneur who has started two companies based on his experience as an iGEM Team Leader.

BridgeBio aims to  bring iGEMers and iGEM stakeholders, industrialists, and bio-founders closer together to  benefit each other in different areas and strengthen iGEM and synthetic biology in their  community.

While the global synthetic biology landscape grows each year, regional communities play a vital role cultivating synbio ecosystems. Read their stories on our upcoming SynBio Alliance Blog Series, starting today with some highlights on the special issue on "Global Synthetic Biology Landscape" from Biotech Note.

iGEM influenced me a lot to be who I am today. iGEM makes me see that biology can be integrated with digitalisation and “machinery”.

iGEM acted as my gateway into exploring research in biology, which I might not have actively looked into otherwise. I would say iGEM happens to be one of the means by which I found my liking for synthetic and quantitative biology.